|
1
|
Han BK, Kuzin I, Gaughan JP, Olsen NJ and
Bottaro A: Baseline CXCL10 and CXCL13 levels are predictive
biomarkers for tumor necrosis factor inhibitor therapy in patients
with moderate to severe rheumatoid arthritis: A pilot, prospective
study. Arthritis Res Ther. 18:932016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor PC, Moore A, Vasilescu R, Alvir J
and Tarallo M: A structured literature review of the burden of
illness and unmet needs in patients with rheumatoid arthritis: A
current perspective. Rheumatol Int. 36:685–695. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kirwan JR and Boers M: Biological
treatment in rheumatoid arthritis: When to stop? Lancet.
383:288–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pincus T, Gibson KA and Castrejón I:
Update on methotrexate as the anchor drug for rheumatoid arthritis.
Bull Hosp Jt Dis (2013). 71 Suppl 1:S9–S19. 2013.PubMed/NCBI
|
|
5
|
Halilova KI, Brown EE, Morgan SL, Bridges
SL Jr, Hwang MH, Arnett DK and Danila MI: Markers of treatment
response to methotrexate in rheumatoid arthritis: Where do we
stand? Int J Rheumatol. 2012:9783962012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiff M and Bessette L: Evaluation of
abatacept in biologic-naive patients with active rheumatoid
arthritis. Clin Rheumatol. 29:583–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Emery P: Optimizing outcomes in patients
with rheumatoid arthritis and an inadequate response to anti-TNF
treatment. Rheumatology (Oxford). 51 Suppl 5:v22–v30. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eriksson JK, Karlsson JA, Bratt J,
Petersson IF, van Vollenhoven RF, Ernestam S, Geborek P and Neovius
M: Cost-effectiveness of infliximab versus conventional combination
treatment in methotrexate-refractory early rheumatoid arthritis:
2-year results of the register-enriched randomised controlled
SWEFOT trial. Ann Rheum Dis. 74:1094–1101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meissner B, Trivedi D, You M and
Rosenblatt L: Switching of biologic disease modifying
anti-rheumatic drugs in patients with rheumatoid arthritis in a
real world setting. J Med Econ. 17:259–265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He YT, Ou AH, Yang XB, Chen W, Fu LY, Lu
AP, Yan XP, Feng XH, Su L, Song YJ, et al: Traditional Chinese
medicine versus western medicine as used in China in the management
of rheumatoid arthritis: A randomized, single-blind, 24-week study.
Rheumatol Int. 34:1647–1655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
American College of Rheumatology Committee
to Reevaluate Improvement Criteria: A proposed revision to the
ACR20: The hybrid measure of American college of rheumatology
response. Arthritis Rheum. 57:193–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang DZ, Sun SG, Li W and Zheng FZ:
Experimental study of processing semen strychni on the effect of
anti-Inflammatory in adjuvant arthritis rats. China J Chin Med.
30:539–541. 2015.(In Chinese).
|
|
13
|
Feng QS, Wang GF, Wang QS, Gao LN and Cui
YL: Anti-inflammatory activity comparison of aqueous extract with
monomer components of Biqi capsule. Chin J Exp Tradit Med Formul.
22:89–93. 2016.
|
|
14
|
He XW, Fan XP, Zhong T and He Y: Research
progress on new drug delivery system of brucine to treat rheumatoid
arthritis. Chin Arch Tradit Chin Med. 33:2908–2911. 2015.(In
Chinese).
|
|
15
|
Liu W: Clinical observation of Biqi
capsule on rheumatoid arthritis. Tianjin J Transit Chin Med.
21:474–475. 2004.(In Chinese).
|
|
16
|
Gao J, Zeng Y, Yu F, Zhuang LN, Yang L and
Liu CX: Full side and dismantlement study on anti-inflammatory and
analgesic effect of Biqi capsule. Chin Tradit Herbal Drugs.
40:93–96. 2009.(In Chinese).
|
|
17
|
Liu W and Liu XY: Research the effect of
Biqi capsule on human cartilage glycoprotein-39 in peripheral blood
mononuclear cells of patients with rheumatoid arthritis. China J
TCM Pharm. 24:391–392. 2009.(In Chinese).
|
|
18
|
Liu W, Wu YH, Liu XY, Shen W and Wang P:
Protective effect of the drug-containing serum with Biqi capsule on
articular chondrocytes in vitro. China J Tradit Chin Med Pharm.
25:1283–1286. 2010.(In Chinese).
|
|
19
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. J Clin Epidemiol.
62:1006–1012. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: Is blinding necessary?
Control Clin Trials. 17:1–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Higgins JP, Altman DG, Gøtzsche PC, Jüni
P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et
al: The Cochrane Collaboration's tool for assessing risk of bias in
randomised trials. BMJ. 343:d59282011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu W, Zhang L, Zhou YL and Liu XY:
Influence of Biqi capsule on cytokine in rheumatoid arthritis.
Tianjin J Tradit Chin Med. 22:290–291. 2005.
|
|
24
|
Bai HT and Li J: Clinical observation on
50 cases of Biqi capsule for treatment of rheumatoid arthritis.
China J Tradit Chin Med Pharm. 24:1489–1490. 2009.(In Chinese).
|
|
25
|
Jie HY, Wu QF and Ding ZX: Clinical study
of Biqi capsule combined with methotrexate for treatment of
rheumatoid arthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi.
32:195–198. 2012.(In Chinese). PubMed/NCBI
|
|
26
|
Wan HJ, Liu J, Xu JY and Fang HY: The
efficacy of Biqi capsules combined with low dose methotrexate in
the treatment of rheumatoid arthritis. Chin J Biochem Pharm.
33:669–671. 2012.
|
|
27
|
Rao L, Shen CJ, Shi ZQ and Yang J: Effects
of integrated traditional and western medicine on rheumatoid
arthritis. China J Tradit Chin Med Pharm. 31:546–548. 2016.(In
Chinese).
|
|
28
|
Wu Q, Ding Z, Lu Y, Sun D, Feng L, Jie H,
Su X, Chen W and Tang H: Clinical study of Biqi capsule for
treatment of rheumatism. Proceedings of the 8th National Conference
on Rheumatic Diseases in Traditional Chinese Medicine and Western
Medicine. 104–109. 2010.(In Chinese).
|
|
29
|
Yun C: Treatment of rheumatoid arthritis
with Biqi capsule in 36 cases. J Pract Tradit Chin Med.
20:5092004.
|
|
30
|
Xu YM, Rong XF, Tan HF and Peng FF:
Effects of Chinese medicine Biqi capsule on the expressions of
JAK/STAT signal pathways in CIA rats. Immunol J. 31:1072–1076.
2015.
|
|
31
|
Bian XQ and Liu W: Experimental study on
pharmacodynamics of Biqi capsule for treatment of rheumatoid
arthritis. China J Tradit Chin Med Pharm. 21:773–774. 2006.
|
|
32
|
Weinblatt ME, Maier AL, Fraser PA and
Coblyn JS: Longterm prospective study of methotrexate in rheumatoid
arthritis: Conclusion after 132 months of therapy. J Rheumatol.
25:238–242. 1998.PubMed/NCBI
|
